Wrapping up Q1 earnings, we look at the numbers and key takeaways for the property & casualty insurance stocks, including Trupanion (NASDAQ:TRUP) and its peers. Property & Casualty (P&C) insurers ...

Trupanion is a trustworthy pet insurance company, receiving a “Great” rating from Trustpilot and averaging 4.1 out of 5 stars based on more than 7,000 Trupanion reviews.

Trupanion (TRUP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Zacks •last month ...

After recently reporting results for the second quarter, pet insurer Trupanion (TRUP 2.45%) is definitely expanding its enrolled-pets membership base. But is the stock a buy for growth investors?

Trupanion provides medical insurance for cats and dogs throughout the United States, Canada and Peurto Rico. Global pet insurance market is expected to grow at 8% CAGR until 2026.

Trupanion has higher loss ratios and higher premiums than its competitors, which will squeeze it between a rock and a hard place. Read why TRUP stock is a Sell.

Trupanion says its preliminary fourth-quarter 2023 revenue grew 20% year over year to $295.9 million, translating to a net loss of $2.2 million, or $0.05 per share (narrowed from a loss of $0.23 ...

Trupanion (TRUP) shares ended the last trading session 9.9% higher at $22.60. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

Pet health insurance provider Trupanion (TRUP 1.73%) isn't a typical Warren Buffett stock, but that doesn't mean the Oracle of Omaha would completely shun it. Though you won't find human health ...

Trupanion says it is the second largest pet insurance provider in North America with more than 275,000 enrolled pets as of last November. But it says it wants to grow to as much as 750,000 animals ...